Abstract

Molecular techniques for identifying pathogens associated with cancer continue to
be developed, including one reported recently in BMC Medical Genomics. Identifying a causal infectious agent helps in understanding the biology of these
cancers and can lead ultimately to the development of antimicrobial drugs and vaccines
for their treatment and prevention.